• By Jessica Scott, MGC, CGC
  • Posted January 15, 2025

From Fear to Empowerment: A Patient's Perspective on the Ambry CARE Program

We talk about the Ambry CARE Program® (CARE) a lot – how it helps providers identify high-risk patients, offers genetic testing and genetic counseling at scale, and gives patients insights to help them better manage their health. All of that is very powerful, but people also often ask what CARE looks like from the patient’s perspective.…


  • By Jenna Cooke, DNP, APRN, FNP-C, CGRA
  • Posted December 18, 2024

Enhancing Patient Care: A Digital Approach via The Ambry CARE Program® Improves Universal Cancer Risk Stratification in Imaging Centers

Identifying individuals at increased cancer risk is crucial for prevention and early cancer diagnosis. Integrating a risk assessment tool into imaging centers supports proactive cancer risk management by combining risk evaluation with immediate diagnostic capabilities. A retrospective study was conducted across 15 Midstate Radiology Associates…


  • By Rebecca Carr, MS, CGC
  • Posted December 17, 2024

Navigating Hereditary Cancer Testing: Selecting the Right Multigene Panel

Navigating the complex world of genetic testing can be daunting, especially with the rapidly evolving landscape of hereditary cancer testing. For healthcare providers, choosing the right hereditary cancer test and laboratory is crucial to offer the best care for their patients. The Evolution of Hereditary Cancer Testing Genetic testing was…


  • By Amanda Jacquart, MS, LCGC
  • Posted December 4, 2024

Understanding Gene-Disease Validity in Hereditary Cancer Testing

My favorite thing about my role as a Genomic Science Liaison (GSL) at Ambry is that I get to apply my training in genetic counseling and experience working in an oncology clinic to conversations with healthcare providers about genetic testing and technology, helping them make the most informed decisions for their patients. In this blog, I have…


  • By Lauren Costantin, MS, CGC
  • Posted November 21, 2024

Progeny Spotlight: Empowering Families with Health History Insights

Thanksgiving has always been my favorite holiday–it is a time to gather around the table with family from near and far, to eat a delicious meal, and catch up on everyone’s accomplishments over the past year. Thanksgiving is also National Family Health History Day, so as we are enjoying another helping of mashed potatoes this year, why not take…


  • By Melissa Holman, MS, CGC
  • Posted November 15, 2024

How the Ambry Patient for Life™ Program Minimizes the Need for Provider-Initiated Exome Reanalysis Requests

Understanding Exome Reanalysis Exome reanalysis is a process that involves assessing all 20,000 of a patient's genes, despite only having a concrete understanding of the functions of around 5,000 to 6,000. However, the gap in this understanding is rapidly closing. Scientific research characterizes approximately one new gene every two days. Therefore,…


  • By Jessica Grzybowski, MS, CGC
  • Posted October 31, 2024

Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach

In the fast-moving world of genetic testing, designing and updating a hereditary cancer portfolio and each test it includes is a balancing act. It’s about making sure we include genes that matter clinically while steering clear of those with uncertain links to cancer. At Ambry, we’ve perfected this balancing act by sticking to a process rooted…


  • By Catherine Mayo, MS, CGC
  • Posted October 31, 2024

Early Detection in Action: Angie’s CARE Story

October is Breast Cancer Awareness Month. Some of the best defensive strategies against breast cancer are early detection and risk reduction, but high-risk individuals can be missed with some routine screening processes. The Ambry CARE Program® (CARE) helps healthcare providers consistently identify high-risk patients by assessing patients’…


  • By Elizabeth Chao, MD, FACMG
  • Posted October 17, 2024

The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment

Hereditary cancer testing has changed dramatically over the past decade, reshaping how healthcare professionals diagnose and manage genetic risks. Initially, testing focused on specific genes like BRCA1 and BRCA2, linked to breast and ovarian cancers. These gene tests were quite limited, only looking at a small set of mutations…


  • By Jessica Scott, MGC, CGC
  • Posted October 16, 2024

Polyposis Explained: Solving the Mystery with RNA Testing

As a genetic counselor at Cone Cancer Center for the last twelve years, Karen Powell, CGC, enjoys helping patients understand their cancer risks. Hereditary cancer testing may provide important and possibly life-saving information for not only the patient but their family members as well. Many patients present with a family history of cancer,…